News & Updates

Current status: 967 hESC lines, 5572 hiPSC lines, and 136 clinical studies, and 1934 certificates

Posted on March 1, 2024 by Statistic Bot ... Continue reading
total lines6539
hESC lines967
hiPSC lines5572
derivation countries46
projects 293
providers883
... Continue reading
total lines6401
hESC lines960
hiPSC lines5441
derivation countries46
projects 288
providers879
... Continue reading
total lines6319
hESC lines957
hiPSC lines5362
derivation countries46
projects 282
providers874
... Continue reading
total lines6239
hESC lines956
hiPSC lines5283
derivation countries46
projects 282
providers866
... Continue reading
total lines6189
hESC lines949
hiPSC lines5240
derivation countries46
projects 281
providers856
... Continue reading
total lines5988
hESC lines938
hiPSC lines5050
derivation countries46
projects 277
providers843
... Continue reading
total lines5334
hESC lines937
hiPSC lines4397
derivation countries46
projects 277
providers837
... Continue reading
total lines5273
hESC lines932
hiPSC lines4341
derivation countries46
projects 276
providers829
... Continue reading
total lines5184
hESC lines898
hiPSC lines4286
derivation countries46
projects 273
providers822
... Continue reading
total lines4845
hESC lines895
hiPSC lines3950
derivation countries46
projects 272
providers814
... Continue reading
total lines4776
hESC lines894
hiPSC lines3882
derivation countries45
projects 268
providers810
... Continue reading

66 newly registered hiPSC lines from CIRM (Alzheimer’s disease collection, CW13)

Posted on March 14, 2023 by Stefanie Seltmann The Alzheimer’s disease collection (CW13) has been registered in hPSCreg®, consisting of 22 iPSC lines generated from late-onset Alzheimer’s disease patients (female:15) and 44 controls (female:37). These iPSC lines, funded and owned by the California Institute for Regenerative Med
total lines4586
hESC lines878
hiPSC lines3708
derivation countries45
projects 264
providers801
... Continue reading

Current status: 873 hESC lines, 3634 hiPSC lines, and 111 clinical studies, and 523 certificates

Posted on March 1, 2023 by Statistic Bot ... Continue reading
total lines4507
hESC lines873
hiPSC lines3634
derivation countries45
projects 261
providers798
... Continue reading

WHO International Clinical Trials Registry Platform (ICTRP) lists hPSCreg

Posted on January 10, 2023 by Stefanie Seltmann The hPSCreg clinical study database is now listed on the WHO "s International Clinical Trials Registry Platform (ICTRP) as an External Search Platform! https://www.who.int/clinical-trials-registry-platform/the-ictrp-search-portal/external-search-platforms hPSCreg is a knowledgebase about human p
total lines4362
hESC lines864
hiPSC lines3498
derivation countries45
projects 258
providers783
... Continue reading

Current status: 886 hESC lines, 3431 hiPSC lines, and 109 clinical studies, and 449 certificates

Posted on January 1, 2023 by Statistic Bot ... Continue reading
total lines4317
hESC lines886
hiPSC lines3431
derivation countries44
projects 256
providers772
... Continue reading
total lines4250
hESC lines873
hiPSC lines3377
derivation countries44
projects 249
providers767
... Continue reading

100 clinical studies using hPSC-derived cells!

Posted on October 13, 2022 by Stefanie Seltmann Over 100 clinical studies using hPSC-derived cells can now be found at hPSCreg®! Have a look at the 100th study: A Study To Evaluate Safety, Engraftment, And Efficacy Of VC-01 In Subjects With T1 Diabetes Mellitus (VC01-103) Or check out the hPSCreg® clinical studies database
total lines4211
hESC lines873
hiPSC lines3338
derivation countries43
projects 248
providers764
... Continue reading

Current status: 857 hESC lines, 3298 hiPSC lines, and 100 clinical studies, and 442 certificates

Posted on October 1, 2022 by Statistic Bot ... Continue reading
total lines4155
hESC lines857
hiPSC lines3298
derivation countries43
projects 246
providers751
... Continue reading
total lines4107
hESC lines839
hiPSC lines3268
derivation countries43
projects 245
providers750
... Continue reading
total lines4063
hESC lines834
hiPSC lines3229
derivation countries43
projects 244
providers740
... Continue reading

Join us at the ISSCR

Posted on June 16, 2022 by Stefanie Seltmann Whether you’re joining us in person in San Francisco or logging on virtually, be sure to connect with us from June 15 - 18. You can find us at the poster session with poster #206 and #207
total lines4040
hESC lines832
hiPSC lines3208
derivation countries43
projects 237
providers734
... Continue reading

Current status: 832 hESC lines, 3179 hiPSC lines, and 97 clinical studies, and 417 certificates

Posted on June 1, 2022 by Statistic Bot ... Continue reading
total lines4011
hESC lines832
hiPSC lines3179
derivation countries43
projects 234
providers725
... Continue reading

Current status: 831 hESC lines, 3142 hiPSC lines, and 97 clinical studies, and 409 certificates

Posted on May 1, 2022 by Statistic Bot ... Continue reading
total lines3973
hESC lines831
hiPSC lines3142
derivation countries43
projects 230
providers716
... Continue reading
total lines3920
hESC lines827
hiPSC lines3093
derivation countries43
projects 223
providers707
... Continue reading
total lines3885
hESC lines827
hiPSC lines3058
derivation countries40
projects 219
providers699
... Continue reading
total lines3841
hESC lines824
hiPSC lines3017
derivation countries40
projects 217
providers691
... Continue reading
total lines3802
hESC lines820
hiPSC lines2982
derivation countries40
projects 211
providers677
... Continue reading
Total lines3762
hESC lines819
hiPSC lines2943
derivation countries40
projects 211
providers671
... Continue reading

New Video: Developments to simplify and accelerate iPSC research

Posted on October 28, 2021 by Stefanie Seltmann Have a look at the new video from the EBiSC project. This ISSCR's focus session details how EBiSC2 partners are adapting and consolidating iPSC expansion, differentiation and cryopreservation approaches to help ease transition into high volume applications whilst also ensuring accessibility for n
Total lines3727
hESC lines810
hiPSC lines2917
derivation countries40
projects 208
providers659
... Continue reading

Current status: 807 hESC lines, 2902 hiPSC lines, and 85 clinical studies

Posted on October 1, 2021 by Statistic Bot ... Continue reading
Total lines3709
hESC lines807
hiPSC lines2902
derivation countries40
projects 206
providers647
... Continue reading
Total lines3671
hESC lines806
hiPSC lines2865
derivation countries40
projects 205
providers632
... Continue reading
Total lines3628
hESC lines804
hiPSC lines2824
derivation countries40
projects 205
providers623
... Continue reading
Total lines3600
hESC lines801
hiPSC lines2799
derivation countries40
projects 204
providers608
... Continue reading
Total lines3528
hESC lines799
hiPSC lines2729
derivation countries40
projects 203
providers594
... Continue reading
Total lines3493
hESC lines794
hiPSC lines2699
derivation countries40
projects 198
providers579
... Continue reading
Total lines3462
hESC lines792
hiPSC lines2670
derivation countries40
projects 195
providers570
... Continue reading
Total lines3445
hESC lines791
hiPSC lines2654
derivation countries40
projects 193
providers556
... Continue reading
Total lines3419
hESC lines789
hiPSC lines2630
derivation countries40
projects 190
providers544
... Continue reading
Total lines3367
hESC lines788
hiPSC lines2579
derivation countries40
projects 184
providers535
... Continue reading
Total lines3344
hESC lines788
hiPSC lines2556
derivation countries40
projects 180
providers531
... Continue reading
Total lines3280
hESC lines782
hiPSC lines2498
derivation countries40
projects 180
providers523
... Continue reading
Total lines3268
hESC lines780
hiPSC lines2488
derivation countries40
projects 178
providers505
... Continue reading
Total lines3229
hESC lines779
hiPSC lines2450
derivation countries40
projects 176
providers490
... Continue reading
Total lines3196
hESC lines776
hiPSC lines2420
derivation countries40
projects 174
providers482
... Continue reading

Current status: 776 hESC lines, 2385 hiPSC lines, and 57 clinical studies

Posted on July 1, 2020 by Statistic Bot ... Continue reading
Total lines3161
hESC lines776
hiPSC lines2385
derivation countries39
projects 171
providers469
... Continue reading
Total lines3153
hESC lines774
hiPSC lines2379
derivation countries38
projects 169
providers461
... Continue reading
Total lines3122
hESC lines774
hiPSC lines2348
derivation countries38
projects 165
providers455
... Continue reading
Total lines3104
hESC lines773
hiPSC lines2331
derivation countries37
projects 162
providers443
... Continue reading
Total lines3070
hESC lines767
hiPSC lines2303
derivation countries36
projects 159
providers431
... Continue reading

hPSCreg as a resource in IRDiRC

Posted on January 15, 2020 by Stefanie Seltmann We are pleased that hPSCreg is now entered as a recognized resource in the International Rare Diseases Research Consortium ( IRDiRC ). Patient-derived hiPSC lines are valuable source reagents for producing specific cell types for use in individualized disease modeling and drug testing, especiall
Total lines3051
hESC lines764
hiPSC lines2287
derivation countries36
projects 157
providers424
... Continue reading

Current status: 754 hESC lines, 2275 hiPSC lines, and 42 clinical studies

Posted on January 1, 2020 by Statistic Bot ... Continue reading

ISCBI supports the hPSCreg standard nomenclature

Posted on December 4, 2019 by Stefanie Seltmann We are pleased that the International Stem Cell Banking Initiative (ISCBI) has published a call for the implementation of the standard pluripotent stem cell (hPSC) nomenclature. The ISCBI strongly recommends the registration of hPSC - standard names in hPSCreg . More details can be found here
Total lines3029
hESC lines754
hiPSC lines2275
derivation countries35
projects 155
providers414
... Continue reading

Current status: 750 hESC lines, 2222 hiPSC lines, and 42 clinical studies

Posted on December 1, 2019 by Statistic Bot ... Continue reading
Total lines2972
hESC lines750
hiPSC lines2222
derivation countries34
projects 149
providers400
... Continue reading

Join us at the 1st Advanced Therapies Science Meeting in Berlin

Posted on October 2, 2019 by Stefanie Seltmann The 1st Advanced Therapies Science Meeting from Restore will take place at 25. and 26. November 2019 in Berlin. Dr. Andreas Kurtz from hPSCreg will talk about "Ethics management" and "Stem cell data standards". We hope to meet you at the meeting and look forward to fruitful discussions.
Total lines2896
hESC lines747
hiPSC lines2149
derivation countries33
projects 146
providers387
... Continue reading

Current status: 746 hESC lines, 2079 hiPSC lines, and 42 clinical studies

Posted on October 1, 2019 by Statistic Bot ... Continue reading
Total lines2825
hESC lines746
hiPSC lines2079
derivation countries32
projects 141
providers374
... Continue reading

new publication on ethical provenance of cell lines

Posted on August 23, 2019 by Stefanie Seltmann We are happy that our new publication "A pathway for attesting ethical provenance of cell lines: Lessons from the European human pluripotent stem cell registry (hPSCreg)" has been released. You can find the publication here
Total lines2783
hESC lines746
hiPSC lines2037
derivation countries32
projects 140
providers366
... Continue reading

Current status: 744 hESC lines, 1974 hiPSC lines, and 39 clinical studies

Posted on August 1, 2019 by Statistic Bot ... Continue reading

Please take part in the User Survey from EBiSC

Posted on July 23, 2019 by Stefanie Seltmann The European Bank of induced pluripotent Stem Cells EBiSC is looking for your input as international iPSC scientists. The user survey to gather feedback on your requirements from an iPSC repository is now available . This includes assessing provision of: Specific disease variant iPSCs
Total lines2718
hESC lines744
hiPSC lines1974
derivation countries32
projects 139
providers359
... Continue reading

Current status: 744 hESC lines, 1949 hiPSC lines, and 39 trials

Posted on July 1, 2019 by Statistic Bot ... Continue reading
Total lines2693
hESC lines744
hiPSC lines1949
derivation countries31
projects 136
providers348
... Continue reading
Total lines2662
hESC lines741
hiPSC lines1921
derivation countries31
projects 132
providers337
... Continue reading
Total lines2642
hESC lines741
hiPSC lines1901
derivation countries31
projects 130
providers331
... Continue reading

clinical studies on hPSCreg

Posted on March 28, 2019 by Stefanie Seltmann Due to the great progress in the field of research on pluripotent stem cell lines and their application in the clinical area, hPSCreg now also offers an overview of studies and the associated cell lines. The overview is publicly available here. Registered users also have the option of registering
Total lines2619
hESC lines739
hiPSC lines1880
derivation countries31
projects 127
providers318
... Continue reading

Current status: 739 hESC lines and 1873 hiPSC lines

Posted on March 1, 2019 by Statistic Bot ... Continue reading
Total lines2612
hESC lines739
hiPSC lines1873
derivation countries31
projects 125
providers309
... Continue reading
Total lines2607
hESC lines739
hiPSC lines1868
derivation countries31
projects 123
providers303
... Continue reading
Total lines2604
hESC lines739
hiPSC lines1865
derivation countries31
projects 120
providers293
... Continue reading
Total lines2597
hESC lines738
hiPSC lines1859
derivation countries30
projects 118
providers284
... Continue reading
Total lines2586
hESC lines738
hiPSC lines1848
derivation countries30
projects 118
providers282
... Continue reading
Total lines2570
hESC lines738
hiPSC lines1832
derivation countries30
projects 113
providers272
Total lines2571
hESC lines739
iPSC lines1832
derivation countries30
projects 111
providers256
... Continue reading

Recent Trends in Research with Human Pluripotent Stem Cells

Posted on July 30, 2018 by Stefanie Seltmann We want to highlight a new publication: Recent Trends in Research with Human Pluripotent Stem Cells: Impact of Research and Use of Cell Lines in Experimental Research and Clinical Trials The human pluripotent stem cell (hPSC) research landscape is rapidly evolving. To assess possible novel trend ... Continue reading

GDPR Policy update

Posted on May 25, 2018 by Stefanie Seltmann We have updated our Terms of Use and Privacy Policy to make it easy for the hPSCreg user to understand what information we have about them, what we do with it, and why. While we believe this updated policy will serve all of our users better, we are making these changes to make sure that we are compl ... Continue reading

New: Provide public comments or feedback for cell lines

Posted on March 6, 2018 by Robert Müller Registered hPSCreg users can now publicly share feedback, experiences or results with the research community for each cell line. When logged in, you can provide comments directly within the cell line details page in the „General“ section. ... Continue reading

Simplification of publishing your lines

Posted on September 19, 2017 by Stefanie Seltmann hPSCreg now provides an automatic, pre-filled word template to publish your cell line in Stem Cell Research - Lab Resources. The template can be downloaded after the cell line has been submitted. For further details click here. ... Continue reading

Current status: 707 hESC lines and 574 iPSC lines

Posted on August 1, 2017 by Statistic Bot ... Continue reading
Total lines1281
hESC lines707
iPSC lines574
derivation countries28
projects 99
providers173
... Continue reading
Total lines1278
hESC lines706
iPSC lines572
derivation countries27
projects 94
providers167
... Continue reading
Total lines1264
hESC lines706
iPSC lines558
derivation countries26
projects 91
providers159
... Continue reading
Total lines1229
hESC lines706
iPSC lines523
derivation countries26
projects 91
providers151
... Continue reading
Total lines1212
hESC lines703
iPSC lines509
derivation countries26
projects 87
providers140
... Continue reading

New API to list hPSCreg names

Posted on February 28, 2017 by Johannes Dewender We have a new public API to list all hPSCreg cell line names and to find the hPSCreg name for a cell line. See the documentation for details.
Total lines1176
hESC lines695
iPSC lines481
derivation countries26
projects 84
providers130
... Continue reading

Current status: 690 hESC lines and 452 iPSC lines

Posted on February 1, 2017 by Statistic Bot ... Continue reading
Total lines1142
hESC lines690
iPSC lines452
derivation countries27
projects 83
providers129
... Continue reading
Total lines1137
hESC lines699
iPSC lines438
derivation countries27
projects 82
providers122
... Continue reading
Total lines1130
hESC lines701
iPSC lines429
derivation countries27
projects 76
providers117
... Continue reading
Total lines1128
hESC lines701
iPSC lines427
derivation countries27
projects 71
providers116
... Continue reading
Total lines1116
hESC lines698
iPSC lines418
derivation countries27
projects 71
providers116
... Continue reading
Total lines1105
hESC lines698
iPSC lines407
derivation countries27
projects 68
providers116
... Continue reading
Total lines1095
hESC lines693
iPSC lines402
derivation countries26
projects 66
providers113
... Continue reading
Total lines1068
hESC lines693
iPSC lines375
derivation countries26
projects 66
providers110
... Continue reading
Total lines1015
hESC lines693
iPSC lines322
derivation countries26
projects 66
providers109
... Continue reading
Total lines1015
hESC lines693
iPSC lines322
derivation countries26
projects 66
providers108
Total lines 848
hESC lines 691
iPSC lines 157
derivation countries 26
projects 64
providers 107
... Continue reading

Partnership with Elsevier’s Journal Stem Cell Research

Posted on August 31, 2015 by Stefanie Seltmann The Human Pluripotent Stem Cell Registry has entered an agreement to publish the description of cell lines registered with hPSCreg under the article type “Lab Resource: Stem Cell Line” in the journal Stem Cell Research. Scientists registering their PSC lines in hPSCreg will have the opportuni ... Continue reading

Press release on BioSpace.com

Posted on June 24, 2015 by Weiping Zhang BioSpace.com features a press release about the Human Pluripotent Stem Cell Registry hPSCreg; "A global registry has been enhanced and expanded to offer more in-depth information and analysis on human pluripotent stem cell lines, including human embryonic (hESC) and adult derived induced pluripot ... Continue reading

World map of ES and iPS cell lines is online

Posted on February 18, 2015 by Fritz Lekschas World map of ES and iPS cell lines is now online. Currently the map shows the (log) number of registered ES and iPS cell lines as well as the legal status for ES cell line research in a heat map fashion. To open the world map click on it or visit hescreg.eu/map. ... Continue reading

The hESCreg portal was publicly relaunched

Posted on November 4, 2014 by Robert Müller The hESCreg portal was publicly relaunched on November 4 at the German Stem Cell Network's (GSCN) annual conference in Heidelberg. The re-launch adds new and expanded functionality to the portal, including an online registration tool for human embryonic and induced pluripotent cell lines and the aut ... Continue reading

Abandoned embryonic stem cell trial to re-start

Posted on June 11, 2014 by Robert Müller The first ever clinical trial using human embryonic stem cell – derived oligodendrocytes has received new funding, after it was abandoned by Geron in 2011 (Nature 479, 459; 2011). The 14.3 million US$ provided by CIRM to Asterias Biotherapeutics of Menlo Park, California will be used to treat and ... Continue reading

Reprogramming by somatic cell nuclear transfer

Posted on June 3, 2014 by Robert Müller Three recent papers have successfully reprogrammed human adult somatic cells by somatic cell nuclear transfer (SCNT) into oocytes (de Souza, 2014). While the first successful human pluripotent NT-line were derived from fetal dermal fibroblasts and dermal fibroblasts from a patient with Leigh syndro ... Continue reading

A New Regulatory System for Stem Cell–Based Therapies in Japan

Posted on June 3, 2014 by Robert Müller The Japanese government has implemented a novel regulatory framework for stem cell based therapies: The Act on the Safety of Regenerative Medicine and the Revised Pharmaceutical Affairs Law. Recognizing that the conventional regulatory framework for pharmaceuticals is unsuitable for cell based regen ... Continue reading

EBiSC – the first European bank for induced pluripotent stem cells

Posted on March 26, 2014 by Hermann Azong A consortium of 26 partners has been formed to establish the “European Bank for induced pluripotent Stem Cells” (EBiSC) with support from the IMI. The EBISC iPS cell bank will act as a central storage and distribution facility for human iPS cells, to be used by researchers across academi ... Continue reading